Compounds > 3-hydroxyephedrine
Page last updated: 2024-08-22

3-hydroxyephedrine and Central Nervous System Neoplasm

3-hydroxyephedrine has been researched along with Central Nervous System Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G1

Reviews

1 review(s) available for 3-hydroxyephedrine and Central Nervous System Neoplasm

ArticleYear
PET/CT imaging in neuroblastoma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed

2013